Hello to all,
 I was wondering who out there is performing correlating studies when a new 
antibody is purchased.  One of our paths thought we should be doing this 
everytime we introduce a new antibody to our IP collection, which would mean 
sending 10 to 20 cases to a reference lab or other lab and have them stain 
them with the new Ab. Then also performing the same test in-house, then 
correlating the results. What are the rules (if any) on this sort of thing 
(for inspection purposes, etc.)?  Any info would be greatly appreciated.  I 
apologize if this subject has already come up....


Thanks!
Jeanne Godine
Pathology Consultants